Triage AI, software, and growth decisions across a portfolio

Improve portfolio value and reduce avoidable technology risk by directing attention, expertise, and capital toward the companies and constraints where intervention can matter.

The pressure you are holding

• Every company presents a different AI story, maturity level, architecture, and evidence standard
• Board-level urgency can produce pilot activity without operating ownership or measurable value
• Technical debt, product risk, cybersecurity exposure, and delivery capacity are difficult to compare before they affect the plan
• Shared vendors or playbooks may create leverage in one company and harmful constraint in another
• Partner, financing, acquisition, and exit processes require credible technical and commercial evidence on short timelines

Questions worth resolving before scale

1. Which portfolio opportunities deserve deeper diligence, a proof sprint, operating help, or no further investment?
2. What is the deployable and supportable truth behind each product, roadmap, security posture, and AI claim?
3. Which capabilities, vendors, controls, and evaluation patterns can be shared, and which must remain company-specific?
4. Where would a focused engineering, product, automation, security, or GTM intervention change the value-creation plan?
5. What evidence and remediation should be ready before financing, partnership, acquisition, customer diligence, or exit?

• A portfolio triage view with comparable opportunity, risk, evidence, ownership, dependency, and next-action fields
• Targeted diligence and proof plans for the assumptions most capable of changing an investment or operating decision
• Company-specific remediation and value-creation work with accountable executives and measurable gates
• Reusable patterns for AI evaluation, security, governance, delivery, and commercial proof where they genuinely fit
• A clearer evidence package for boards, counterparties, customers, partners, and authorized diligence

The engagement path

1. Create a comparable portfolio view. We use a common rubric for business outcome, product, architecture, data, AI, security, compliance, delivery, adoption, economics, leadership, evidence, and urgency while preserving company context.
2. Select the intervention. Each company receives a recommendation such as observe, diligence, stop, buy, prove, remediate, augment, rebuild, automate, reposition, or prepare, with an owner and rationale.
3. Execute with company leadership. Focused teams work inside the portfolio company’s systems and governance. Production, commercial, security, and operating proof—not portfolio theater—governs scope and continuation.
4. Return evidence to the value plan. Results, remaining risk, capability, repeatable patterns, and next gates are reported in a comparable form and connected to board, financing, partnership, acquisition, or exit decisions.

Decision criteria to keep visible

• Portfolio comparison uses a shared evidence model without substituting a universal architecture or vendor for company context
• Technical and commercial claims distinguish reproduced evidence, management representation, hypothesis, and unknown
• Interventions have a named portfolio sponsor, company executive owner, decision gate, transfer plan, and measurable operating result
• Customer, employee, company, investor, and counterparty information remains properly authorized and confidential
• Investment decisions, securities activity, legal conclusions, formal assurance, and risk acceptance remain with qualified and authorized parties

Questions teams ask